These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 11930196)
21. ERCP: present practice in a single region. Suggested standards for monitoring performance. Tanner AR Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):145-8. PubMed ID: 8723419 [TBL] [Abstract][Full Text] [Related]
24. Frequency of common factors for post endoscopic retrograde cholangiopancreatography pancreatitis. Haqqi SA; Mansoor-ul-Haq M; Shaikh H J Coll Physicians Surg Pak; 2011 Aug; 21(8):464-7. PubMed ID: 21798131 [TBL] [Abstract][Full Text] [Related]
25. [Complications of endoscopic retrograde cholangiopancreatography]. Plewka M; Rysz J; Kujawski K Pol Merkur Lekarski; 2017 Dec; 43(258):272-275. PubMed ID: 29298967 [TBL] [Abstract][Full Text] [Related]
26. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail. Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246 [TBL] [Abstract][Full Text] [Related]
31. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography. Balmadrid B; Kozarek R Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966 [TBL] [Abstract][Full Text] [Related]
32. Value of Raw Rhubarb Solution in the Precaution of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Patients with High-Risk Factors: A Predictive Random Compared Research in One Center. Wang C; Li Q; Ye P; Zeng S; Li GH; Chen YX; Zhou XJ; Lv NH Dig Dis Sci; 2017 Apr; 62(4):1043-1050. PubMed ID: 28194668 [TBL] [Abstract][Full Text] [Related]
33. ERCP and reprocessing in focus: what can we do to prevent or manage infection outbreaks? Beilenhoff U Endoscopy; 2015 Jun; 47(6):483-5. PubMed ID: 26030889 [No Abstract] [Full Text] [Related]
35. Endoscopic retrograde cholangiopancreatography-related adverse events: general overview. Rustagi T; Jamidar PA Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):97-106. PubMed ID: 25442961 [TBL] [Abstract][Full Text] [Related]
36. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study. Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054 [TBL] [Abstract][Full Text] [Related]
37. How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Leerhøy B; Elmunzer BJ Gastrointest Endosc Clin N Am; 2018 Oct; 28(4):439-454. PubMed ID: 30241637 [TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis. Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544 [TBL] [Abstract][Full Text] [Related]
39. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Kapral C; Mühlberger A; Wewalka F; Duller C; Knoflach P; Schreiber F; Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1447-54. PubMed ID: 23114747 [TBL] [Abstract][Full Text] [Related]
40. Fifty years of ERCP: a personal review. Cotton PB Gastrointest Endosc; 2018 Aug; 88(2):393-396. PubMed ID: 29654739 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]